Literature DB >> 34223797

Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome.

Austin D Igelman1, Cristy Ku1, Mariana Matioli da Palma1,2, Michalis Georgiou3,4, Elena R Schiff3,4, Byron L Lam5, Eeva-Marja Sankila6, Jeeyun Ahn7,8, Lindsey Pyers7, Ajoy Vincent9,10, Juliana Maria Ferraz Sallum2, Wadih M Zein11, Jin Kyun Oh12,13, Ramiro S Maldonado14, Joseph Ryu12, Stephen H Tsang12,15, Michael B Gorin7,16, Andrew R Webster3,4, Michel Michaelides3,4, Paul Yang1, Mark E Pennesi1.   

Abstract

Atypical Usher syndrome (USH) is poorly defined with a broad clinical spectrum. Here, we characterize the clinical phenotype of disease caused by variants in CEP78, CEP250, ARSG, and ABHD12.Chart review evaluating demographic, clinical, imaging, and genetic findings of 19 patients from 18 families with a clinical diagnosis of retinal disease and confirmed disease-causing variants in CEP78, CEP250, ARSG, or ABHD12.CEP78-related disease included sensorineural hearing loss (SNHL) in 6/7 patients and demonstrated a broad phenotypic spectrum including: vascular attenuation, pallor of the optic disc, intraretinal pigment, retinal pigment epithelium mottling, areas of mid-peripheral hypo-autofluorescence, outer retinal atrophy, mild pigmentary changes in the macula, foveal hypo-autofluorescence, and granularity of the ellipsoid zone. Nonsense and frameshift variants in CEP250 showed mild retinal disease with progressive, non-congenital SNHL. ARSG variants resulted in a characteristic pericentral pattern of hypo-autofluorescence with one patient reporting non-congenital SNHL. ABHD12-related disease showed rod-cone dystrophy with macular involvement, early and severe decreased best corrected visual acuity, and non-congenital SNHL ranging from unreported to severe.This study serves to expand the clinical phenotypes of atypical USH. Given the variable findings, atypical USH should be considered in patients with peripheral and macular retinal disease even without the typical RP phenotype especially when SNHL is noted. Additionally, genetic screening may be useful in patients who have clinical symptoms and retinal findings even in the absence of known SNHL given the variability of atypical USH.

Entities:  

Keywords:  ABHD12; ARSG; Atypical usher syndrome; CEP78; cep250

Mesh:

Substances:

Year:  2021        PMID: 34223797      PMCID: PMC9233901          DOI: 10.1080/13816810.2021.1946704

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.274


  35 in total

1.  Comprehensive Molecular Screening in Chinese Usher Syndrome Patients.

Authors:  Tengyang Sun; Ke Xu; Yanfan Ren; Yue Xie; Xiaohui Zhang; Lu Tian; Yang Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-01       Impact factor: 4.799

2.  Genotype-phenotype correlation in a novel ABHD12 mutation underlying PHARC syndrome.

Authors:  Andreas Thimm; Ahmad Rahal; Ulrike Schoen; Angela Abicht; Stephan Klebe; Christoph Kleinschnitz; Tim Hagenacker; Mark Stettner
Journal:  J Peripher Nerv Syst       Date:  2020-02-24       Impact factor: 3.494

3.  A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis.

Authors:  Marie Abitbol; Jean-Laurent Thibaud; Natasha J Olby; Christophe Hitte; Jean-Philippe Puech; Marie Maurer; Fanny Pilot-Storck; Benoit Hédan; Stéphane Dréano; Sandra Brahimi; Delphine Delattre; Catherine André; Françoise Gray; Françoise Delisle; Catherine Caillaud; Florence Bernex; Jean-Jacques Panthier; Geneviève Aubin-Houzelstein; Stéphane Blot; Laurent Tiret
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.

Authors:  Konstantinos Nikopoulos; Pietro Farinelli; Basilio Giangreco; Chrysanthi Tsika; Beryl Royer-Bertrand; Martial K Mbefo; Nicola Bedoni; Ulrika Kjellström; Ikram El Zaoui; Silvio Alessandro Di Gioia; Sara Balzano; Katarina Cisarova; Andrea Messina; Sarah Decembrini; Sotiris Plainis; Styliani V Blazaki; Muhammad Imran Khan; Shazia Micheal; Karsten Boldt; Marius Ueffing; Alexandre P Moulin; Frans P M Cremers; Ronald Roepman; Yvan Arsenijevic; Miltiadis K Tsilimbaris; Sten Andréasson; Carlo Rivolta
Journal:  Am J Hum Genet       Date:  2016-09-01       Impact factor: 11.025

5.  Functional characterization of CEP250 variant identified in nonsyndromic retinitis pigmentosa.

Authors:  Xiu-Feng Huang; Lue Xiang; Xiao-Long Fang; Wei-Qin Liu; You-Yuan Zhuang; Zhen-Ji Chen; Ren-Juan Shen; Wan Cheng; Ru-Yi Han; Si-Si Zheng; Xue-Jiao Chen; Xiaoling Liu; Zi-Bing Jin
Journal:  Hum Mutat       Date:  2019-04-18       Impact factor: 4.878

6.  Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.

Authors:  J D Eudy; M D Weston; S Yao; D M Hoover; H L Rehm; M Ma-Edmonds; D Yan; I Ahmad; J J Cheng; C Ayuso; C Cremers; S Davenport; C Moller; C B Talmadge; K W Beisel; M Tamayo; C C Morton; A Swaroop; W J Kimberling; J Sumegi
Journal:  Science       Date:  1998-06-12       Impact factor: 47.728

7.  CEP78 is mutated in a distinct type of Usher syndrome.

Authors:  Qing Fu; Mingchu Xu; Xue Chen; Xunlun Sheng; Zhisheng Yuan; Yani Liu; Huajin Li; Zixi Sun; Huiping Li; Lizhu Yang; Keqing Wang; Fangxia Zhang; Yumei Li; Chen Zhao; Ruifang Sui; Rui Chen
Journal:  J Med Genet       Date:  2016-09-14       Impact factor: 6.318

8.  Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II.

Authors:  Michael D Weston; Mirjam W J Luijendijk; Kurt D Humphrey; Claes Möller; William J Kimberling
Journal:  Am J Hum Genet       Date:  2004-01-20       Impact factor: 11.025

9.  A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical Usher syndrome in humans.

Authors:  Samer Khateb; Björn Kowalewski; Nicola Bedoni; Markus Damme; Netta Pollack; Ann Saada; Alexey Obolensky; Tamar Ben-Yosef; Menachem Gross; Thomas Dierks; Eyal Banin; Carlo Rivolta; Dror Sharon
Journal:  Genet Med       Date:  2018-01-04       Impact factor: 8.822

10.  Identification of a novel homozygous ARSG mutation as the second cause of Usher syndrome type 4.

Authors:  Víctor Abad-Morales; Rafael Navarro; Anniken Burés-Jelstrup; Esther Pomares
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-08
View more
  3 in total

Review 1.  The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification.

Authors:  Sedigheh Delmaghani; Aziz El-Amraoui
Journal:  Hum Genet       Date:  2022-03-30       Impact factor: 5.881

2.  Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants.

Authors:  Hannie Kremer; Cornelis P Lanting; Markus Damme; Hedwig M Velde; Janine Reurink; Sebastian Held; Catherina H Z Li; Suzanne Yzer; Jaap Oostrik; Jack Weeda; Lonneke Haer-Wigman; Helger G Yntema; Susanne Roosing; Laurenz Pauleikhoff; Clemens Lange; Laura Whelan; Adrian Dockery; Julia Zhu; David J Keegan; G Jane Farrar; Ronald J E Pennings
Journal:  Hum Genet       Date:  2022-02-28       Impact factor: 5.881

3.  The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12: An Ophthalmic Perspective.

Authors:  Xuan-Thanh-An Nguyen; Hind Almushattat; Ine Strubbe; Michalis Georgiou; Catherina H Z Li; Mary J van Schooneveld; Inge Joniau; Elfride De Baere; Ralph J Florijn; Arthur A Bergen; Carel B Hoyng; Michel Michaelides; Bart P Leroy; Camiel J F Boon
Journal:  Genes (Basel)       Date:  2021-09-11       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.